Authors
Loading...
Meta-analysis shows treosulfan improves overall response and reduces non-relapse mortality in hematopoietic stem cell transplantation for MDS and AML, pointing to its potential as a safer alternative.
Sawaira et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: